Acute neuropharmacologic action of chloroquine on cortical neurons in vitro
暂无分享,去创建一个
David A Stenger | Joseph J Pancrazio | Guenter W Gross | G. Gross | D. Stenger | K. M. Shaffer | J. Pancrazio | Wu Ma | T. O'shaughnessy | Wu Ma | Kara M Shaffer | Bret Zim | Thomas J O’Shaughnessy | Bret Zim | Kaveh Zamani | K. Zamani
[1] I. Gluzman,et al. Antimalarials increase vesicle pH in Plasmodium falciparum , 1985, The Journal of cell biology.
[2] H. Baba,et al. Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn , 1998, The Journal of physiology.
[3] M. Milone,et al. Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission , 1996, Brain Research.
[4] F. Riesen,et al. Neurotoxic effects of chloroquine in vitro , 2005, Archives of Toxicology.
[5] D. Stenger,et al. Development and Application of Cell-Based Biosensors , 1999, Annals of Biomedical Engineering.
[6] R. Wightman,et al. Amine Weak Bases Disrupt Vesicular Storage and Promote Exocytosis in Chromaffin Cells , 1999, Journal of neurochemistry.
[7] R. Shader,et al. Lethality and Behavioral Side Effects of Chloroquine , 1982, Journal of clinical psychopharmacology.
[8] P. Bernard. Alterations of auditory evoked potentials during the course of chloroquine treatment. , 1985, Acta oto-laryngologica.
[9] D A Stenger,et al. Inhibition of spontaneous GABAergic transmission by trimethylolpropane phosphate. , 1999, Neurotoxicology.
[10] D. Stenger,et al. Identification of differential gene expression profiles in rat cortical cells exposed to the neuroactive agents trimethylolpropane phosphate and bicuculline. , 2001, Biosensors & bioelectronics.
[11] P. Olliaro,et al. Mode of action and mechanisms of resistance for antimalarial drugs. , 2001, Pharmacology & therapeutics.
[12] G. Gross,et al. Transparent indium-tin oxide electrode patterns for extracellular, multisite recording in neuronal cultures , 1985, Journal of Neuroscience Methods.
[13] J. Noebels,et al. Presynaptic Ca2+ Channels and Neurotransmitter Release at the Terminal of a Mouse Cortical Neuron , 2001, The Journal of Neuroscience.
[14] Thomas M. McKenna,et al. Enabling Technologies for Cultured Neural Networks , 1994 .
[15] Effects of quinine on three different types of potassium currents in bullfrog sympathetic neurons , 1999, Neuroscience Letters.
[16] G. Gross,et al. Neurophysiologic effects of chemical agent hydrolysis products on cortical neurons in vitro. , 2001, Neurotoxicology.
[17] Guenter W. Gross,et al. Neuronal networks for biochemical sensing , 1992 .
[18] A. Schousboe,et al. Localization and pharmacological characterization of voltage dependent calcium channels in cultured neocortical neurons , 2001, International Journal of Developmental Neuroscience.
[19] F. Deák,et al. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells , 2000, Neuropharmacology.
[20] A. Bacci,et al. A TTX-sensitive conductance underlying burst firing in isolated pyramidal neurons from rat neocortex , 1996, Brain Research.
[21] J. Bernal,et al. Antimalarial drugs inhibit calcium-dependent backward swimming and calcium currents in Paramecium calkinsi , 1993, Journal of Comparative Physiology A.
[22] G. Gross,et al. Characterization of acute neurotoxic effects of trimethylolpropane phosphate via neuronal network biosensors. , 2001, Biosensors & bioelectronics.
[23] E. Kravitz,et al. Presynaptic action of the neurosteroid pregnenolone sulfate on inhibitory transmitter release in cultured hippocampal neurons , 1997, Brain Research.
[24] B. Sakmann,et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.
[25] J. Sánchez-Chapula,et al. Chloroquine blocks the background potassium current in guinea pig atrial myocytes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[26] G. Gross. Simultaneous Single Unit Recording in vitro with a Photoetched Laser Deinsulated Gold Multimicroelectrode Surface , 1979, IEEE Transactions on Biomedical Engineering.
[27] K. Miller,et al. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. , 1988, The New England journal of medicine.
[28] P. Phillips-Howard,et al. CNS Adverse Events Associated With Antimalarial Agents , 1995, Drug safety.
[29] D. Warhurst,et al. Lysosomes, pH and the Anti-malarial Action of Chloroquine , 1972, Nature.
[30] G. Gross,et al. The use of neuronal networks on multielectrode arrays as biosensors. , 1995, Biosensors & bioelectronics.
[31] D. Sulzer,et al. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action , 1990, Neuron.
[32] I. Gluzman,et al. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. , 1994, The Journal of clinical investigation.
[33] A. Harsch,et al. Odor, drug and toxin analysis with neuronal networks in vitro: extracellular array recording of network responses. , 1997, Biosensors & bioelectronics.
[34] G. Pasternak,et al. Interactions of chloroquine with benzodiazepine, γ-aminobutyric acid and opiate receptors , 1991 .
[35] D. Warrell,et al. Divided dose intramuscular regimen and single dose subcutaneous regimen for chloroquine: plasma concentrations and toxicity in patients with malaria. , 1986, British medical journal.
[36] U. Misgeld,et al. GABAB receptor‐mediated inhibition of spontaneous inhibitory synaptic currents in rat midbrain culture. , 1997, The Journal of physiology.
[37] Coatney Gr. Pitfalls in a Discovery: The Chronicle of Chloroquine , 1963 .
[38] X. Lin,et al. Effects of quinine on the excitability and voltage-dependent currents of isolated spiral ganglion neurons in culture. , 1998, Journal of neurophysiology.
[39] R. Day,et al. Antimalarials in rheumatic diseases. , 1990, Bailliere's clinical rheumatology.